Natriumwaterstofcarbonaat (Sodium Hydrogen Carbonate)

Sodium hydrogen carbonate, the active ingredient in Natriumwaterstofcarbonaat, is an excipient presented as an intravenous solution for intravenous use. It provides bicarbonate ions that act as a buffering agent to correct metabolic acidosis and maintain acid‑base balance when administered intravenously.

GNH USA supplies Natriumwaterstofcarbonaat as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Natriumwaterstofcarbonaat acts as a buffering agent in conditions where acid‑base balance is disturbed. - Metabolic acidosis: corrects low blood pH by supplying bicarbonate ions. - Renal replacement therapy: helps maintain systemic pH during dialysis. - Cardiopulmonary bypass surgery: supports acid‑base homeostasis during the procedure.

Adverse reactions may occur with intravenous sodium hydrogen carbonate administration.

Common Side Effects: - Hypernatremia: elevated serum sodium levels. - Metabolic alkalosis: excessive increase in blood pH. - Fluid overload: volume expansion leading to edema. - Hypokalemia: reduced serum potassium. - Local IV site irritation: pain or phlebitis at infusion site. - Transient rise in arterial CO₂: due to rapid bicarbonate conversion.

Serious or Rare Side Effects: - Severe metabolic alkalosis: can cause respiratory depression. - Cardiac arrhythmias: secondary to electrolyte disturbances. - Pulmonary edema: from fluid overload. - Severe hypernatremia: neurologic impairment. - Anaphylactic reaction: rare hypersensitivity. - Life‑threatening electrolyte imbalance: requiring urgent correction.

When using Natriumwaterstofcarbonaat, clinicians should observe several safety measures. - Renal impairment: monitor serum electrolytes and fluid status. - Cardiac disease: watch for signs of fluid overload and arrhythmias. - Respiratory compromise: avoid rapid infusion that may increase CO₂ retention. - Pregnancy: safety not established; use only if benefit outweighs risk. - Concomitant alkalinizing agents: avoid overcorrection of pH. - Store at ambient temperature: keep in original container, protect from moisture and light.

Sodium hydrogen carbonate may interact with other medications affecting acid‑base balance or electrolyte status.

Major Interactions (Avoid): - Concurrent use with other alkalinizing agents (e.g., sodium citrate) – risk of severe alkalosis. - Combination with loop diuretics – may exacerbate metabolic alkalosis.

Moderate Interactions (Monitor Closely): - Co‑administration with potassium‑sparing diuretics – monitor potassium levels. - Use with antacids – may alter gastric pH and affect drug absorption. - Concurrent insulin therapy – monitor for shifts in potassium. - Certain antibiotics (e.g., penicillins) – may affect urinary excretion; monitor renal function.